Skin Substitutes Fraud Investigations: What Wound Care Providers Need to Know in 2026

If your practice bills Medicare for amniotic allografts or other skin substitutes, you are working in the most heavily scrutinized corner of American healthcare. In 2026, federal prosecutors made wound care the lead story of a record-setting health care fraud takedown, and new indictments have followed every few weeks since. Many providers now under federal investigation never saw themselves as targets. They bought grafts from distributors who promised the billing was routine, and they treated patients with real wounds.

That is exactly why early legal advice matters. Below, we explain why skin substitutes fraud became a federal priority, the theories prosecutors rely on, and what providers should do the moment they sense trouble.

Why Skin Substitutes Fraud Became DOJ’s Top Healthcare Fraud Target

For years, Medicare paid for most skin substitutes based on manufacturer-reported sales prices. Some products were reimbursed at more than $2,000 per square centimeter, turning a patient with a wound into a six- or seven-figure billing event. Part B spending on these products exploded in just a few years, and investigators followed the money.

The June 2026 National Health Care Fraud Takedown charged 455 defendants nationwide, and the Justice Department opened its announcement with 11 wound care defendants across six federal districts. In August, a Henderson, Nevada physician was indicted on charges that he billed Medicare more than $95 million for amniotic allografts, including grafts applied to hospice patients. (As DOJ itself notes, an indictment is merely an allegation.) A senior Justice Department official said earlier this year that many more skin substitute cases are in the pipeline.

The Fraud Theories Prosecutors Are Using

Wound care cases rarely rest on a single bad claim. Prosecutors build them around patterns, and the same theories appear in indictment after indictment:

• Medical necessity. Grafts applied to infected, healed or superficial wounds, or applied before conservative care was tried.
• Quantity. Billing for graft sizes that far exceed the measured wound, or for product that was never applied.
• Kickbacks disguised as rebates. Distributors returning a share of reimbursement through “rebate agreements,” profit splits, or pass-through accounts, conduct that falls squarely within the reach of the federal Anti-Kickback Statute.
• Sham invoices. Keeping an inflated “full-price” invoice for Medicare documentation requests while paying a far lower real price.
• Vulnerable patients. Concentrated billing on elderly, homebound, or hospice beneficiaries, which prosecutors present to juries as an aggravating fact.

The same facts can support a criminal health care fraud charge under 18 U.S.C. § 1347, a civil False Claims Act case, or both. Whether a matter stays civil often turns on what investigators believe the provider knew, which is why the government invests in proving intent in healthcare fraud cases through emails, text messages, and testimony from former staff.

The 2026 Payment Overhaul Does Not Close the Book

Starting January 1, 2026, CMS stopped paying for most skin substitutes as separately priced biologicals and began treating them as incident-to supplies paid at a flat rate of roughly $127 per square centimeter. The change removes much of the financial incentive behind these schemes, but it does nothing for claims already paid. Investigators are working backward through years of reimbursement under the old system, and those claims remain fully exposed.

Providers should also expect auditors to compare billing before and after the rate change. A practice whose graft volume collapsed overnight on January 1 may find that pattern used as evidence that earlier volume was driven by reimbursement rather than clinical need.

How Wound Care Investigations Begin

Most providers do not learn about an investigation from an indictment. The first sign is usually one of the following:

• A records request or prepayment review from a Unified Program Integrity Contractor
• A Medicare payment suspension based on a credible allegation of fraud
• A grand jury subpoena or a DOJ civil investigative demand
• A seizure warrant against a practice bank account, which a Pasadena wound care clinic experienced in April 2026, a reminder of how quickly federal asset forfeiture can freeze an operating business
• Agents interviewing your staff, your patients, or your distributor’s sales representatives

DOJ’s health care fraud data team now monitors claims for sudden spikes. A practice whose graft billing jumps sharply from one month to the next can draw attention long before anyone files a complaint.

Clinical Judgment Is Still a Defense in Wound Care Fraud Cases

Not every high-volume wound care practice is committing fraud. Chronic diabetic and venous ulcers are common among Medicare beneficiaries, and skin substitutes can be medically appropriate when standard care has failed. Prosecutors must prove that a provider knowingly submitted false claims, not simply that an auditor would have treated the wound differently.

A strong defense often starts with the medical record. Providers can show serial wound measurements, dated photographs, documentation of failed conservative treatment, and notes explaining why a particular graft size was chosen. Independent wound care experts can review those records and testify that the treatment fell within accepted clinical practice. When the government’s case rests on statistical extrapolation and outliers rather than patient-level evidence, that distinction can be decisive, and often shapes whether prosecutors are willing to resolve a matter civilly.

What to Do If Your Wound Care Practice Is Under Scrutiny

1. Stay silent until you have counsel. Do not discuss graft billing with agents, auditors, or distributor representatives on your own.
2. Preserve everything. Wound measurements, photographs, invoices, rebate agreements, and distributor emails all matter. Deleting records can create a separate obstruction charge.
3. Do not coordinate stories. Contacting employees about what they will tell investigators can look like witness tampering.
4. Document what you actually paid. Acquisition records can rebut allegations built on inflated invoices.
5. Let counsel shape every response. A Medicare ADR response becomes evidence the moment you submit it.

Early intervention can sometimes keep a matter administrative or civil, limit repayment by challenging an extrapolated overpayment, or persuade prosecutors that clinical judgment, not fraud, explains the billing. Once charges are filed, those options narrow considerably, and sometimes disappear altogether.

Wound Care and Skin Substitute Fraud: Frequently Asked Questions

Can I be charged if I relied on my distributor’s reimbursement guidance?

Possibly. Good-faith reliance on outside advice can be a defense, but only if you disclosed all the relevant facts and genuinely followed the guidance. Prosecutors routinely argue that providers knew the “reimbursement support” offered by a graft distributor was a sales pitch, not neutral advice. Distributor representatives who cooperate with the government often become the key witnesses against the practices they once serviced.

Are volume discounts from graft suppliers ever legal?

Yes. The Anti-Kickback Statute has a discount safe harbor, but only for price reductions that are properly documented and disclosed. The costs you should reflect the amount in the report or bill. A “discount” that is hidden from Medicare, paid back later through side accounts, or offered in exchange for referrals falls outside that protection and can be prosecuted as a kickback.

Do private insurers investigate skin substitute billing too?

Yes. The federal health care fraud statute covers private health plans as well as Medicare, and at least one 2026 wound care indictment listed commercial insurers, TRICARE and CHAMPVA among the alleged victims. Commercial carriers also run their own special investigation units, which can demand records and claw back payments, potentially leading to a referral to federal prosecutors.

How far back can the government look at my claims?

The general federal statute of limitations for criminal health care fraud is five years. Civil False Claims Act cases can reach back six years. In some circumstances, the government can extend the statute of limitations up to ten years from the violation. Conspiracy charges can extend the reach further because the clock may not start until the last act of the conspiracy.

Can my medical license be affected even if I am never convicted?

Yes. State licensing boards can open their own proceedings based on the same allegations, and the HHS Office of Inspector General can seek to exclude a provider from federal health care programs after a civil settlement or certain administrative findings. Licensing exposure should be managed alongside the federal investigation from the start.

Should I stop using skin substitutes once I learn about an investigation?

Not necessarily, and not without advice. Abruptly halting a clinically appropriate treatment can harm patients and may be portrayed as an admission. Most practices are better served by tightening documentation, adding peer review for graft decisions, and having counsel review protocols before making any change in treatment.

What should I do if federal agents arrive at my clinic?

Be polite, ask for identification and any warrant, and call a defense lawyer immediately. You and your staff are not required to answer questions. Our guide to what to do when FBI agents want to interview you explains how to protect yourself without obstructing the agents.

Am I responsible for grafts my nurse practitioners or physician assistants billed under my NPI?

You can be. When services are billed under a supervising physician’s number, the government may argue that the physician knew what was submitted, and civil False Claims Act liability can rest on reckless disregard alone. Your exposure depends on what you actually knew, how supervision worked in practice and who controlled billing decisions.

How is “loss” calculated if I am convicted?

Under the federal sentencing guidelines, the total amount billed to a government health care program is treated as initial evidence of the intended loss in a federal health care offense. That can push the sentencing range far higher than what Medicare actually paid, which makes challenging the loss figure one of the most important parts of the defense.

Can a former employee start a skin substitute case against my practice?

Yes. Under the False Claims Act’s qui tam provisions, employees, billers, and sales representatives can file sealed lawsuits and share in any recovery. Some of the largest wound care resolutions began this way. A practice may not learn about a qui tam suit until the government has investigated it for months.

Speak With a Federal Wound Care Fraud Defense Lawyer Today

Lowther | Walker defends physicians, nurse practitioners, and practice owners in federal fraud investigations across all 50 states.

Our attorneys secured “not guilty” verdicts on every count at retrial in a $1.4 billion health care fraud prosecution involving toxicology laboratories and rural hospitals, persuaded prosecutors to decline charges entirely against a former laboratory director in a matter involving $100 million in Medicare reimbursements, and convinced the government not to prosecute a client tied to a roughly $30 million telemedicine kickback investigation involving DME and genetic testing. We bring that same approach to healthcare fraud defense for wound care providers. Our lawyers are available 24 hours a day, 7 days a week, 365 days a year, and every consultation is free and confidential.

If you have received a subpoena, a records request, a payment suspension, or a call from a federal agent about skin substitute billing, the steps you take in the next few days can shape everything that follows. Call Lowther | Walker at (404) 496-4052 or contact our team online for a free, confidential consultation.